Persistent inflationary pressure and consecutive rate hikes have hit the U.S. economy’s growth prospects and raised fears of a recession. Amid this, investing in defensive stocks Coca-Cola (KO), Humana (HUM),…
Author archives: Anushka Dutta
Is Salesforce Stock a Buy Right Now or Should You Wait?
Tech company Salesforce (CRM) has reiterated its ambitious long-term revenue target and announced new profitability goals. However, with the stock slumping in price lately, should you invest in it now…
1 Popular EV Stock Insiders Are Selling Right Now
Electric vehicle company Mullen Automotive’s (MULN) CEO has sold its shares on seven separate occasions this year, with total shares sold counting to more than 2 million. Moreover, MULN has…
1 Stock to Dump This Week if You Haven’t Already
Chip-making giant NVIDIA (NVDA) has received restrictions on exporting its top chips to China. Moreover, the company’s bleak fundamentals look concerning. Hence, it might be wise to avoid NVDA now….
Layoffs Spell Trouble for This 1 Retail Stock
Apparel retailer Gap Inc. (GPS) has reported substantial employee layoffs recently, which indicates the business turbulence the company is facing. Hence, this might not be the right time to invest…
1 Sector ETF to Buy Before All of the Rest
The Utilities Select Sector SPDR Fund (XLU) has outperformed the broader market this year. As the utility sector usually holds up well in downturns, this ETF might be a solid…
1 Stock You Should Leave out of Your Retirement Portfolio
Apparel retailer Gap Inc.’s (GPS) annual dividend yields handsomely. However, its dividend payouts have been declining over the past few years. And given its bleak fundamental positioning, I think the…
3 Gold Stocks to Sell Heading Into Q4
Gold is facing headwinds from a strong U.S. dollar and the expectations of aggressive interest rate hikes. Therefore, we believe gold stocks Buenaventura Mining (BVN), Hycroft Mining (HYMC), and GoldMining…
1 Chip Stock With the Power to Become the Next Nvidia
Chip company Micron Technology (MU) is gearing up to make its $15 billion chip factory operational. The company seems poised to recreate an Nvidia (NVDA)-like success story in the coming…
1 Stock That’ll Make You Turn Blue in the Face for Owning
Biotech company bluebird bio (BLUE) received FDA approval for ZYNTEGLO last month, which seems to have boosted its stock price. However, given its bleak profitability and stretched valuations, the stock…